CERTIFICATION PURSUANT TO 18 U.S.C. SECTION
1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of
Elite Pharmaceuticals, Inc. (the “Registrant”) on Form 10-Q for the quarter ended September 30, 2015 filed with the Securities
and Exchange Commission (the “Report”), I, Nasrat Hakim, Chief Executive Officer of the Registrant, certify, pursuant
to 18 U.S. C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and
contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the
|Date: November 9, 2015
||/s/ Nasrat Hakim
||Chief Executive Officer
||of Elite Pharmaceuticals, Inc.
||(Principal Executive Officer)
This certification has been furnished solely pursuant to Section
906 of the Sarbanes-Oxley Act of 2002.
A signed original of this written statement required by Section
906 has been provided to Elite Pharmaceuticals, Inc. and will be retained by Elite Pharmaceuticals, Inc. and furnished to the Securities
and Exchange Commission or its staff upon request.